Omeprazole Prices December 2023
Product
|
Category |
Region |
Price |
Omeprazole |
Pharma API |
USA |
62345 USD/MT (USPFDA) |
Omeprazole |
Pharma API |
China |
60240 USD/MT |
Omeprazole |
Pharma API |
France |
61530 USD/MT (USPFDA) |
The US experienced a decline in consumer confidence and demand due to concerns about interest rates and inflation. The quarter-ending price of Omeprazole in the USA was USD 62345/MT.
Manufacturing output in China declined, reducing demand from local and international consumers. This led to a decrease in orders and sales, causing a significant decrease in prices of Omeprazole. At the end of the quarter, the price of Omeprazole in China was USD 60240/MT (USP, FDA) FOB Shanghai.
The French market for Omeprazole remained stable with moderate supply and steady demand but was affected by constrained availability due to lackluster performance in imported goods. The market is expected to improve with increased demand, improved market dynamics, and new inventories. At the end of the quarter, the price of Omeprazole in France was 61530 USD/MT.
Omeprazole Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Omeprazole Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of omeprazole pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot prices at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of price trends across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing omeprazole price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
Omeprazole Market Analysis
The global omeprazole market size reached US$ 2.7 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 3.8 Billion, at a projected CAGR of 3.80% during 2023-2032.
- The rising prevalence of acid related gastrointestinal disorders such as gastroesophageal reflux disease (GERD) and peptic ulcers significantly impacts the demand for omeprazole. Modern lifestyles which are characterized by sedentary habits add high stress levels along with dietary choices rich in fats and processed foods are further contributing to the increase in the incidence of these conditions. According to a report published by the National Institute of Health, gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal disorders, with a prevalence of approximately 20% of adults in Western culture. This increasing number of gastrointestinal disorders propels the need for effective treatment, thereby driving the omeprazole market growth.
- Omeprazole’s status as a generic medication significantly contributes to its cost effectiveness which makes it a more affordable option as compared to newer proton pump inhibitors (PPIs). The affordability enhances its accessibility which allows a broader range of patients mainly those with limited health care budgets to benefit from the effective acid reduction therapy. The cost-effectiveness ensures that omeprazole maintains its strong position in the market which appeals to both healthcare systems that aim to manage cost and also the patients seeking effective and budget-friendly medication options.
- The global aging population is also one of the significant drivers for the growing demand for omeprazole. As individuals age they naturally experience a decrease in stomach lining protection and often manage chronic conditions that require the use of non-steroidal anti-inflammatory drugs (NSAIDs). According to the data published by World Health Organization (WHO), by 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world’s population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. As the number of older adults increases worldwide the need for omeprazole and other similar treatments is on the rise as well, thereby propelling its market growth.
Omeprazole News
The report covers the latest developments, updates, and trends impacting the global omeprazole market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in omeprazole production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that shape the industry landscape.
Latest developments in the omeprazole industry:
- In 2024, Dr. Reddy's Laboratories entered an exclusive partnership with Sanofi Healthcare India to distribute Sanofi's vaccine brands in India, giving Dr. Reddy's exclusive rights to promote and distribute well-known pediatric and adult vaccines, propelling them to the second position among vaccine players in India.
- In 2023, Pharmaceutical company Lek, a member of the Sandoz Group, had planned a significant investment of EUR 400 million in Lendava, Slovenia, for a high-tech center to produce biosimilars. This investment marked one of the largest foreign direct investments in Slovenia and the largest single investment in Lek's history.
Product Description
Omeprazole is a widely used medication generally classified as a proton pump inhibitor (PPI). Omeprazole works by reducing the amount of acid that is produced in the stomach which makes it highly effective in treating gastroesophageal reflux disease (GERD), stomach ulcers, and many other conditions associated with excessive stomach acid such as Zollinger-Ellison syndrome. Omeprazole is also used in combination with antibiotics to treat helicobacter pylori infections which can cause ulcers. Omeprazole offers relief to patients by allowing damaged tissue in the stomach and esophagus to heal and also helps in the prevention of the recurrence of ulcers. It is available under various brand names and as a generic mainly in capsule or tablet form and is taken orally.
Regional Coverage
The report provides a detailed analysis of the omeprazole market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the price trends.
Global Omeprazole Price
The report offers a holistic view of the global omeprazole pricing trends, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level.
Europe Omeprazole Price
The fourth quarter of 2023 proved challenging for the omeprazole market in Europe. Factors like subdued consumer sentiments, high energy prices, and a surplus of supply impacted prices. Despite this, the French market remained stable with steady demand from end consumers. Lackluster performance in imported goods from prominent exporting countries led to constrained availability.
This analysis can be extended to include detailed omeprazole price information for a comprehensive list of countries.
Region |
Countries Covered |
Europe |
Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Omeprazole Price
In the fourth quarter of 2023, the omeprazole market in North America experienced several significant factors that impacted prices. The overall market dynamics were influenced by various factors, including trading activity, currency fluctuations, and patterns of inflation. Despite these factors, the omeprazole market in North America remained relatively stable, with minimal fluctuations in prices throughout the quarter.
Specific data on omeprazole prices within the United States and Canada can also be provided.
Region |
Countries Covered |
North America |
United States and Canada |
Middle East and Africa Omeprazole Price
The report explores the omeprazole pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on omeprazole prices for countries can also be provided.
Region |
Countries Covered |
Middle East & Africa |
Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Omeprazole Price
The Omeprazole market in the APAC region faced challenges in Q4 2023 due to a contraction in China's manufacturing sector, weak demand both domestically and internationally, and a decline in raw material prices. There was a notable decline in manufacturing output in China, leading to reduced demand from local and international consumers. The prices of omeprazole were further affected by the weakness in the Pyridine market.
This analysis can be further extended to include detailed omeprazole prices for a comprehensive list of countries within the region.
Region |
Countries Covered |
Asia Pacific |
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Omeprazole Price
The analysis of omeprazole prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
Region |
Countries Covered |
Latin America |
Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
Key Attributes |
Details |
Product Name |
Omeprazole |
Report Features |
Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Price Analysis, and Segment-Wise Assessment. |
Currency/Units |
US$ (Data can also be provided in local currency) or Metric Tons |
Region/Countries Covered |
The current coverage includes analysis at the global and regional levels only.
Based on your requirements, we can also customize the report and provide specific information for the following countries:
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*
*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
Information Covered for Key Suppliers |
- Company Overview
- Business Description
- Product Portfolio
- Recent Trends and Developments
|
Customization Scope |
The report can be customized as per the requirements of the customer |
Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
- Scope
- Historical Data for the Current Month
- Forecast for Next Month
- Total Deliverables Per Year: 12 (One Per Month)
- Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year
Plan B: Quarterly Updates - Annual Subscription
- Scope
- Historical Data for the Current Quarter
- Forecast for Next Quarter
- Total Deliverables Per Year: 4 (One Per Quarter)
- Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year
Plan C: Biannually Updates - Annual Subscription
- Scope
- Historical Data for the Current Half
- Forecast for the Next Half
- Total Deliverables Per Year: 2 (One Per 6 Months)
- Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
|
Post-Sale Analyst Support |
360-degree analyst support after report delivery |
Delivery Format |
PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of omeprazole pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting omeprazole price volatility, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights, ensuring they remain at the forefront of the omeprazole industry.